<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Am J Pathol</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Pathol</journal-id>
<journal-title-group>
<journal-title>The American Journal of Pathology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0002-9440</issn>
<issn pub-type="epub">1525-2191</issn>
<publisher>
<publisher-name>American Society for Investigative Pathology</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27768862</article-id>
<article-id pub-id-type="pmc">5225296</article-id>
<article-id pub-id-type="publisher-id">S0002-9440(16)30368-6</article-id>
<article-id pub-id-type="doi">10.1016/j.ajpath.2016.08.013</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Regular Article</subject>
<subj-group>
<subject>Molecular Pathogenesis of Genetic and Inherited Diseases</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Inactivation of <italic>Tsc2</italic> in Mesoderm-Derived Cells Causes Polycystic Kidney Lesions and Impairs Lung Alveolarization</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ren</surname>
<given-names>Siying</given-names>
</name>
<xref ref-type="aff" rid="aff1">∗</xref>
<xref ref-type="aff" rid="aff2">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>Yongfeng</given-names>
</name>
<xref ref-type="aff" rid="aff2">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Hui</given-names>
</name>
<xref ref-type="aff" rid="aff2">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Warburton</surname>
<given-names>David</given-names>
</name>
<xref ref-type="aff" rid="aff2">†</xref>
<xref ref-type="aff" rid="aff3">‡</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lam</surname>
<given-names>Hilaire C.</given-names>
</name>
<xref ref-type="aff" rid="aff4">§</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Larry L.</given-names>
</name>
<xref ref-type="aff" rid="aff2">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Ping</given-names>
</name>
<xref ref-type="aff" rid="aff1">∗</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Henske</surname>
<given-names>Elizabeth P.</given-names>
</name>
<email>ehenske@bwh.harvard.edu</email>
<xref ref-type="aff" rid="aff4">§</xref>
<xref ref-type="corresp" rid="cor2">∗∗</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shi</surname>
<given-names>Wei</given-names>
</name>
<email>wshi@chla.usc.edu</email>
<xref ref-type="aff" rid="aff2">†</xref>
<xref ref-type="aff" rid="aff3">‡</xref>
<xref ref-type="corresp" rid="cor1">∗</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>∗</label>Department of Respiratory Medicine, The Second Xiangya Hospital, Central-South University, Changsha, People's Republic of China</aff>
<aff id="aff2"><label>†</label>Developmental Biology and Regenerative Medicine Program, The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California</aff>
<aff id="aff3"><label>‡</label>Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California</aff>
<aff id="aff4"><label>§</label>Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts</aff>
<author-notes>
<corresp id="cor1"><label>∗</label>Address correspondence to Wei Shi, M.D., Ph.D., Children's Hospital Los Angeles, 4650 Sunset Blvd, MS 35, Los Angeles, CA 90027.Children's Hospital Los Angeles4650 Sunset BlvdMS 35Los AngelesCA90027 <email>wshi@chla.usc.edu</email></corresp>
<corresp id="cor2"><label>∗∗</label>Elizabeth P. Henske, M.D., Thorn 826, Brigham and Women's Hospital, 45 Francis Street, Boston, MA 02115.Thorn 826Brigham and Women's Hospital45 Francis StreetBostonMA02115 <email>ehenske@bwh.harvard.edu</email></corresp>
</author-notes>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>12</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 12 months and 0 days
					and was based on <pub-date pub-type="ppub">.-->
<pub-date pub-type="ppub">
<month>12</month>
<year>2016</year>
</pub-date>
<volume>186</volume>
<issue>12</issue>
<fpage>3261</fpage>
<lpage>3272</lpage>
<history>
<date date-type="accepted">
<day>29</day>
<month>8</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>American Society for Investigative Pathology</copyright-holder>
<license>
<license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
</license>
</permissions>
<abstract id="abs0010">
<p>The tuberous sclerosis complex (TSC) proteins are critical negative regulators of the mammalian/mechanistic target of rapamycin complex 1 pathway. Germline mutations of <italic>TSC1</italic> or <italic>TSC2</italic> cause TSC, affecting multiple organs, including the kidney and lung, and causing substantial morbidity and mortality. The mechanisms of organ-specific disease in TSC remain incompletely understood, and the impact of TSC inactivation on mesenchymal lineage cells has not been specifically studied. We deleted <italic>Tsc2</italic> specifically in mesoderm-derived mesenchymal cells of multiple organs in mice using the <italic>Dermo1-Cre</italic> driver. The <italic>Dermo1-Cre</italic>–driven <italic>Tsc2</italic> conditional knockout mice had body growth retardation and died approximately 3 weeks after birth. Significant phenotypes were observed in the postnatal kidney and lung. Inactivation of <italic>Tsc2</italic> in kidney mesenchyme caused polycystic lesions starting from the second week of age, with increased cell proliferation, tubular epithelial hyperplasia, and epithelial-mesenchymal transition. In contrast, <italic>Tsc2</italic> deletion in lung mesenchyme led to decreased cell proliferation, reduced postnatal alveolarization, and decreased differentiation with reduced numbers of alveolar myofibroblast and type II alveolar epithelial cells. Two major findings thus result from this model: inactivation of Tsc2 in mesoderm-derived cells causes increased cell proliferation in the kidneys but reduced proliferation in the lungs, and inactivation of Tsc2 in mesoderm-derived cells causes epithelial-lined renal cysts. Therefore, <italic>Tsc2</italic>-mTOR signaling in mesenchyme is essential for the maintenance of renal structure and for lung alveolarization.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>